Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21387L |
Nafoxidine
|
Estrogen Receptor/ERR | Endocrinology/Hormones |
Nafoxidine 是一种雌激素拮抗剂,已用于治疗乳腺癌。 | |||
T21387 |
Nafoxidine HCl(1845-11-0 Free base)
PNU-0011100,PNU0011100,CP5600,CP 5600,CP-5600,PNU 0011100,Nafoxidine HCl |
||
Nafoxidine is a partial estrogen antagonist. It inhibits angiogenesis in some tissues by blocking the effects of VEGF and FGF; paradoxically, it may enhance angiogenesis in uterine tissue. Nafoxidine also induces calcium signaling, oxidative stress, and p |